DNTH – dianthus therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Assessing Dianthus Therapeutics (DNTH) Valuation As Price To Book Sits Near 3x And Shares Show Mixed Returns [Yahoo! Finance]
Dianthus Therapeutics (NASDAQ:DNTH) had its price target raised by analysts at Truist Financial Corporation from $56.00 to $63.00. They now have a "buy" rating on the stock.
Dianthus CFO Sells 20,000 Shares for $903,600 After Massive Year-End Run [Yahoo! Finance]
Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference
Form 8-K Dianthus Therapeutics, For: Jan 12
Form 4 Dianthus Therapeutics, For: Dec 04 Filed by: Savitz Ryan
Form 144 Dianthus Therapeutics, Filed by: Savitz Ryan
Form SCHEDULE 13D/A Dianthus Therapeutics, Filed by: Fairmount Funds Management LLC
Form SCHEDULE 13D/A Dianthus Therapeutics, Filed by: Avidity Partners Management LP
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.